UCB has three products currently in phase III which are due to produce pivotal results in the next few years: brivaracetam for epilepsy, lupus treatment epratuzumab and romosozumab for osteoporosis.

Whether it's through stocks, bonds, ETFs, or other types of securities, all investors love seeing their portfolios score big returns. But for income investors, generating consistent cash flow from ...

An extension of the Make HStory campaign that launched last year, this social media effort aims to address misinformation about the chronic skin condition.

Like several other biopharmas before it, UCB has turned to perhaps the most recognizable dermatologist in the U.S. to add ...

The Board of Directors of Financière de Tubizeappoints Bruno Holthof as new Chair As Gaëtan Hannecart did not seek renewal of his director’s mandate at the general shareholders meeting held on April ...

HAWLEY — The Perham track and field team traveled to Dale Skallerud Athletic Complex in Hawley for the UCB Booster Invite on ...

United Community Banks, Inc. operates as the bank holding company for United Community Bank that provides financial products and services to commercial, retail, government, education, energy ...

UNITED COMMUNITY BANKS ($UCB) posted quarterly earnings results on Tuesday, April 22nd. The company reported earnings of $0.59 per share, beating estimates of $0.57 ...

In a report released today, Charles Pitman CFA from Barclays maintained a Buy rating on UCB SA (0NZT – Research Report), with a price target of ...

For the quarter ended March 2025, United Community Banks (UCB) reported revenue of $247.68 million, up 3.7% over the same period last year. EPS came in at $0.59, compared to $0.52 in the year-ago ...